Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G6HZ
|
||||
| Former ID |
DNC004158
|
||||
| Drug Name |
PD-29361
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Terminated | [546624] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C31H36N4O2
|
||||
| Canonical SMILES |
C1CCN(CC1)CC2=CC(=C3C=CNC=C3C2=O)CC4=CC(=C(C5=C4C=CC=N5<br />)O)CN6CCCCC6
|
||||
| InChI |
1S/C31H36N4O2/c36-30-24(20-34-12-3-1-4-13-34)17-22(26-9-11-32-19-28(26)30)16-23-18-25(21-35-14-5-2-6-15-35)31(37)29-27(23)8-7-10-33-29/h7-11,17-19,32,37H,1-6,12-16,20-21H2
|
||||
| InChIKey |
VDZQVHXDGUXCCT-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Voltage-dependent N-type calcium channel | Target Info | Inhibitor | [534799] | |
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Ionotropic glutamate receptor pathway | |||||
| Metabotropic glutamate receptor group III pathway | |||||
| Metabotropic glutamate receptor group II pathway | |||||
| Thyrotropin-releasing hormone receptor signaling pathway | |||||
| Endogenous cannabinoid signaling | |||||
| GABA-B receptor II signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.